Deborah Dewar

4.6k total citations
99 papers, 3.7k citations indexed

About

Deborah Dewar is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Deborah Dewar has authored 99 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cellular and Molecular Neuroscience, 44 papers in Molecular Biology and 33 papers in Physiology. Recurrent topics in Deborah Dewar's work include Neuroscience and Neuropharmacology Research (33 papers), Alzheimer's disease research and treatments (26 papers) and Neuroinflammation and Neurodegeneration Mechanisms (18 papers). Deborah Dewar is often cited by papers focused on Neuroscience and Neuropharmacology Research (33 papers), Alzheimer's disease research and treatments (26 papers) and Neuroinflammation and Neurodegeneration Mechanisms (18 papers). Deborah Dewar collaborates with scholars based in United Kingdom, United States and Italy. Deborah Dewar's co-authors include David I. Graham, James McCulloch, Mark P. Goldberg, Suzanne M. Underhill, James A. R. Nicoll, James McCulloch, Eileen McCracken, Deborah A. Dawson, Elaine Irving and Philippa S. Yam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Stroke.

In The Last Decade

Deborah Dewar

98 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Dewar United Kingdom 34 1.2k 1.2k 1.1k 1.0k 839 99 3.7k
Dale A. Pelligrino United States 41 922 0.7× 1.3k 1.1× 899 0.8× 1.7k 1.7× 1.2k 1.4× 122 5.5k
Karen Horsburgh United Kingdom 41 983 0.8× 1.6k 1.3× 1.7k 1.5× 1.2k 1.2× 836 1.0× 88 4.6k
Brant D. Watson United States 33 1.1k 0.9× 990 0.8× 1.0k 1.0× 605 0.6× 809 1.0× 65 3.9k
Ryuji Hata Japan 36 1.3k 1.0× 2.1k 1.7× 1.2k 1.1× 767 0.8× 447 0.5× 70 4.7k
Alain Buisson France 41 2.0k 1.6× 1.8k 1.6× 1.3k 1.2× 1.6k 1.6× 516 0.6× 79 5.2k
Karsten Ruscher Sweden 36 1.2k 0.9× 1.8k 1.6× 1.5k 1.4× 506 0.5× 658 0.8× 81 5.1k
Henry M. Bartkowski United States 20 1.1k 0.9× 1.2k 1.0× 1.7k 1.6× 435 0.4× 1.2k 1.4× 32 4.9k
Gundars Goldsteins Finland 34 1.1k 0.9× 1.5k 1.3× 1.8k 1.6× 1.3k 1.3× 914 1.1× 50 4.6k
Itender Singh United States 19 940 0.8× 1.2k 1.0× 1.9k 1.7× 1.4k 1.4× 1.1k 1.3× 24 4.8k
Tihomir P. Obrenovitch United Kingdom 35 1.8k 1.5× 1.3k 1.1× 700 0.6× 429 0.4× 628 0.7× 84 3.7k

Countries citing papers authored by Deborah Dewar

Since Specialization
Citations

This map shows the geographic impact of Deborah Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dewar more than expected).

Fields of papers citing papers by Deborah Dewar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dewar. The network helps show where Deborah Dewar may publish in the future.

Co-authorship network of co-authors of Deborah Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Dewar. A scholar is included among the top collaborators of Deborah Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Dewar. Deborah Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arumugam, Thiruma V., Silvia Manzanero, Milena B. Furtado, et al.. (2016). An atypical role for the myeloid receptor Mincle in central nervous system injury. Journal of Cerebral Blood Flow & Metabolism. 37(6). 2098–2111. 39 indexed citations
2.
Lewis, David Y., et al.. (2014). Assessment of [125I]WYE-230949 as a Novel Histamine H3 Receptor Radiopharmaceutical. PLoS ONE. 9(12). e115876–e115876. 3 indexed citations
3.
Hong, Young T., Tonny Veenith, Deborah Dewar, et al.. (2013). Amyloid Imaging With Carbon 11–Labeled Pittsburgh Compound B for Traumatic Brain Injury. JAMA Neurology. 71(1). 23–23. 120 indexed citations
4.
Tavares, Adriana, Deborah Dewar, Andrew Sutherland, et al.. (2012). Iodine‐123 labeled reboxetine analogues for imaging of noradrenaline transporter in brain using single photon emission computed tomography. Synapse. 66(11). 923–930. 1 indexed citations
5.
Kennedy, Laura, Peggy Shelbourne, & Deborah Dewar. (2005). Alterations in dopamine and benzodiazepine receptor binding precede overt neuronal pathology in mice modelling early Huntington disease pathogenesis. Brain Research. 1039(1-2). 14–21. 17 indexed citations
6.
Fowler, Jill H., Eileen McCracken, Deborah Dewar, & James McCulloch. (2003). Intracerebral injection of AMPA causes axonal damage in vivo. Brain Research. 991(1-2). 104–112. 37 indexed citations
7.
McCracken, Eileen, Deborah Dewar, & James McCulloch. (2003). Sipatrigine and oligodendrocyte and axonal pathology following transient focal cerebral ischaemia in the rat. Neuroreport. 14(3). 517–520. 5 indexed citations
8.
Imai, Hirotaka, et al.. (2001). Ebselen protects both gray model of focal and white matter in a rodent cerebral ischemia. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 12 indexed citations
9.
McCracken, Eileen, Andrea Hunter, Shyam A. Patel, David I. Graham, & Deborah Dewar. (1999). Calpain Activation and Cytoskeletal Protein Breakdown in the Corpus Callosum of Head-Injured Patients. Journal of Neurotrauma. 16(9). 749–761. 88 indexed citations
11.
Yam, P.S., James C. Patterson, David I. Graham, et al.. (1998). Topographical and quantitative assessment of white matter injury following a focal ischaemic lesion in the rat brain. Brain Research Protocols. 2(4). 315–322. 32 indexed citations
12.
Perry, EK, et al.. (1998). Cortical Cholinergic Dysfunction After Human Head Injury. Journal of Neurotrauma. 15(5). 295–305. 96 indexed citations
13.
Dewar, Deborah & Deborah A. Dawson. (1997). Changes of cytoskeletal protein immunostaining in myelinated fibre tracts after focal cerebral ischaemia in the rat. Acta Neuropathologica. 93(1). 71–77. 39 indexed citations
14.
Irving, Elaine, James A. R. Nicoll, David I. Graham, & Deborah Dewar. (1996). Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury. Neuroscience Letters. 213(3). 189–192. 58 indexed citations
16.
Dewar, Deborah, et al.. (1996). The neuronal cytoskeleton: an insight for neurosurgeons. British Journal of Neurosurgery. 10(5). 483–488. 3 indexed citations
17.
Dewar, Deborah & Deborah A. Dawson. (1995). Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study. Brain Research. 684(1). 70–78. 75 indexed citations
19.
Ikeda, Masayuki, Deborah Dewar, & James McCulloch. (1993). High affinity hippocampal [3H]-glibenclamide binding sites are preserved in Alzheimer's disease. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 5(3). 177–184. 5 indexed citations
20.
Ikeda, Masayuki, Deborah Dewar, & James McCulloch. (1991). Preservation of [125I]galanin binding sites despite loss of cholinergic neurons to the hippocampus in Alzheimer's disease. Brain Research. 568(1-2). 303–306. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026